Author

S. H. Azam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. E. D. Van Swearingen· 2 shared C. V. Pecot· 2 shared A. D. Cox· 1 shared A. V. Kabanov· 1 shared A. Y. Feng· 1 shared B. Papke· 1 shared C. Gutierrez-Ford· 1 shared C. J. Der· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. E. D. Van Swearingen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Silencing of oncogenic KRAS by mutant-selective small interfering RNA

B. Papke, S. H. Azam, A. Y. Feng, A. E. D. Van Swearingen, C. Gutierrez-Ford, P. S. Pallan, M. Egli, A. D. Cox, C. J. Der, C. V. Pecot

This study develops a mutant-selective siRNA, EFTX-D1, that targets KRAS mutations in codons 12 and 13, reducing mutant KRAS expression and impairing cancer cell proliferation.

bioRxiv · Oct 8, 2020Cancer Biology

High Capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma

N. Vinod, D. Hwang, S. H. Azam, A. E. D. Van Swearingen, E. Wayne, S. C. Fussell, M. Sokolsky-Papkov, C. V. Pecot, A. V. Kabanov

This study shows that a novel nanomicellar formulation of Resiquimod extends survival in a metastatic lung adenocarcinoma model more effectively than chemotherapy and anti-PD1 therapy.

bioRxiv · Dec 12, 2019Pharmacology & Toxicology